Molomics

Molomics, which integrated Artificial Intelligence with Human Collective Intelligence in real-time, was sold to VeriSIM Life in 2022.

[Parc Científic de Barcelona @PCB_UB]

#PCBCommunity | Las operaciones de compra protagonizadas por @Molomics y @Vesismin, con sede en el #PCB_UB, entre los éxitos más relevantes de 2022, según 📰 @ElReferente 📝 Informa @indrakl_ 👇
https://t.co/difeLTgZIJ

[enisa @enisa]

#ClienteEnisa @kompyte @Tiendeo @Glovo_ES @declarando_es @Woffu_App @qustodio @Guudjob @RideReby @Molomics @efimobsolutions @ClupikApp Los exits españoles más destacados del año 2022 vía @ElReferente 

https://t.co/8PB9gu4E0r

[VeriSIM Life @VeriSIMlife]

Meet Dr. Nilesh Gupta, VeriSIM Life’s Senior Director of Business Development, at the American Association of Pharmaceutical Scientists’ PharmSci 360 conference in October. Check it out here: https://t.co/c0RdQCt6lG #AAPS #PharmSci #VeriSIMLife

[buruascientific @buruascientifi1]

Take a look to the new articule published by our founder @melsanm. An interesting job to help to discover a new D1R allosteric modulator. A work started, and mainly carried out, when he wroked at @molomics and finished here in Burua!

[Melchor @melsanm]

New article published! We computationally helped to discover a new D1R allosteric modulator. It could be of interest as a promising therapeutic approach for Parkinson's disease. Check it out!
https://t.co/cJQZZViX0J
#compchem #research #drugdiscovery

[VeriSIM Life @VeriSIMlife]

Come join our amazing team here at VeriSIM Life. We're hiring mission-driven people for multiple roles including Sales and Engineering! Apply here https://t.co/e28VRu4qkz #careers #diversity #lifescience

[Molomics @Molomics]

Great job @melsanm and great science of the medchem group of @unicomplutense done with the support of @Molomics drug discovery technologies, now part of @VeriSIMlife #drugdiscovery #ArtificialIntelligence #compchem

[buruascientific @buruascientifi1]

New article published! We computationally helped to identified the most potent LPA2 antagonist to date which also exhibits functional selectivity against other LPA receptors (LPA1,3-6). Check it out!
https://t.co/XjG65oHciK
#compchem #research #drugdiscovery

[VeriSIM Life @VeriSIMlife]

Learn about BIOiSIM, a virtual drug development engine that narrows down potential drugs for specific diseases or illnesses. Read the white paper on VeriSIM Life’s website https://t.co/JV2nVZj9cZ
#BIOiSIM #drugdevelopment #VeriSIMLife

[The Science of Parkinson's @ScienceofPD]

New data finds "independent of presynaptic dopamine depletion, the thalamus is a major neural substrate for levodopa-induced dyskinesia & that a contracted thalamic shape at baseline is closely associated with an early development of LID" in #Parkinsons
https://t.co/HHPczxVpn0

[Acellera @acellera]

Selective activation of Gαob using #ACEMD and #HTMD. Thanks to the Authors! read more about it at https://t.co/pZFCAXxjeD
#drugdiscovery

[AMG World Events @AMGWorldEvents]

We're delighted to share the panel of #AI experts participating in the AI in Drug Development Virtual Roundtable on 26 July at 10:00 - 11:00 ET.

Register free today: https://t.co/65tMrMiZ5L

@VeriSIMlife @BayerPharma @JanssenGlobal @pfizer

[Mayo Clinic Ventures @MayoInvents]

“This collaboration will explore the full potential of our combined approach to developing best-in-class drug candidates to serve patients’ unmet needs,” said Dr. Jo Varshney, founder and CEO of @VeriSIMlife 🤝 #collaboration #innovation #patientcare https://t.co/pSyaE6TOIu

[Molomics @Molomics]

Muchas gracias @PCB_UB por todo vuestro apoyo durante muchos años. Estamos muy contentos de juntar nuestros esfuerzos con @VeriSIMlife

[Parc Científic de Barcelona @PCB_UB]

🔹La biotech norteamericana @VeriSIMlife adquiere @Molomics
🔝 La startup culminó en el #PCB_UB el desarrollo de una tecnología #deeptech aplicada al diseño de fármacos innovadores que integra la #InteligenciaColectiva humana con la #InteligenciaArtificial
https://t.co/YWal9AvNGm

[OCA Ventures @OCAVentures]

Congratulations @VeriSIMlife on closing your oversubscribed $15M Series A raise! Full feature below via @endpts.

https://t.co/DucF828pfL

[Molomics @Molomics]

Congratulations to the @O_S_M team @MatToddChem @edwintse_ for leading and organizing this #AI competition in #drugdesign. It was a pleasure to participate in this #malaria #openscience study. https://t.co/OJantJXDez

[Dana Klug @dana_klug]

Congratulations @edwintse_ and the entire OSM team!! 🎉🎉

[Molomics @Molomics]

Happy to see that @Molomics recent publication in @jcheminf about #HumanIntelligence has been accessed by more than 1.000 people in 20 days. https://t.co/7zQqLgrnOx #drugdesign #CollectiveIntelligence #medicinalchemist #compchemist

[Molomics @Molomics]

The indispensable role of #medicinalchemists in #drugdesign presented in @jcheminf. #HumanIntelligence rocks! https://t.co/7zQqLgrnOx #passionforchemistry #medchem #ExpertInTheLoop #AIAugmented #CollectiveIntelligence

[Molomics @Molomics]

Do you know what @Foldit and @eternagame have to do with the #crowd sourced case study presented here https://t.co/7zQqLgrnOx by @Molomics? #molecule #drugdesign #cheminformatics

[Molomics @Molomics]

. @Molomics will be attending the Discovery Chemistry US event, taking place on the 15-16 November 2021 #online. Looking forward to great talks and lots of discussions with peers. @drugdiscovery1 #drugdesign #AI #cheminformatics #compchem #medchem #collectiveintelligence